New Narcolepsy Medication 2025 List. Stimulants With final approval, Lumryz becomes the first and only FDA-approved once-at-bedtime oxybate for people living. Medications include: Stimulants such as Modafinil (Provigil) and armodafinil (Nuvigil)
New drugs for treating narcolepsy Download Table from www.researchgate.net
There are more than 80 clinical trials relating to narcolepsy currently underway The Narcolepsy pipeline has 34 drugs in development by companies and one by universities/ institutes
New drugs for treating narcolepsy Download Table
With final approval, Lumryz becomes the first and only FDA-approved once-at-bedtime oxybate for people living. Some of the companies in the Narcolepsy pipeline products market are: Takeda Pharmaceutical, NLS Pharmaceutics and Bioprojet SCR. Based on the results of three controlled phase 2 and 3 efficacy trials and a long-term safety trial of AXS-12 in patients with narcolepsy with cataplexy, Axsome Therapeutics Inc expects to submit a new drug application for AXS-12 (reboxetine) for the treatment of cataplexy in patients with narcolepsy to the US Food and Drug Administration (FDA) in the second half of 2025.
Reevaluating Old and New Therapies for Narcolepsy Neurology Advisor. Based on the results of three controlled phase 2 and 3 efficacy trials and a long-term safety trial of AXS-12 in patients with narcolepsy with cataplexy, Axsome Therapeutics Inc expects to submit a new drug application for AXS-12 (reboxetine) for the treatment of cataplexy in patients with narcolepsy to the US Food and Drug Administration (FDA) in the second half of 2025. 1/17/2025 To treat unresectable or metastatic, HR-positive, HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease
Narcolepsy Causes & Symptoms + Natural Ways to Manage It Dr. Axe. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy Narcolepsy has no cure, but symptoms can be managed with medications and lifestyle adjustments